Physician profile
Hammad V Malik
NPI 1013506583
$683.75
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $177 · 2023: $110 · 2024: $16.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $158.98 | 2021-2022 | |
| Abbvie INC. | $121.01 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $114.81 | 2021-2022 | |
| Dexcom, INC. | $79.21 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.49 | 2021 | |
| Vifor Pharma, INC. | $34.84 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $27.12 | 2021-2022 | |
| Bigfoot Biomedical INC | $23.74 | 2022 | |
| Boston Scientific Corporation | $18.11 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.12 | 2024 | Lifevest |
| Otsuka America Pharmaceutical, INC. | $13.07 | 2021 | |
| Novo Nordisk INC | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.